Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Genetic analysis of circulating metabolic traits in 619,372 individuals

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:14
  • Read more about Genetic analysis of circulating metabolic traits in 619,372 individuals

Plasma protein profile associated with a family history of early-onset coronary heart disease

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:10
  • Read more about Plasma protein profile associated with a family history of early-onset coronary heart disease

Investigating the Causal Link Between Serum Iron Status and Pernicious Anaemia Risk: A Mendelian Randomisation Study

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:07
  • Read more about Investigating the Causal Link Between Serum Iron Status and Pernicious Anaemia Risk: A Mendelian Randomisation Study

Disentangling the relationship between fibromyalgia and insomnia: A bidirectional two-sample Mendelian random analysis

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:02
  • Read more about Disentangling the relationship between fibromyalgia and insomnia: A bidirectional two-sample Mendelian random analysis

Biobank-scale exposome-wide risk factors in cardiometabolic disease: observational, predictive, and causal evidence

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 16:57
  • Read more about Biobank-scale exposome-wide risk factors in cardiometabolic disease: observational, predictive, and causal evidence

Genome-wide association study identifies protective genetic factors in active blood donors against multiple diseases

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 16:53
  • Read more about Genome-wide association study identifies protective genetic factors in active blood donors against multiple diseases

Impulsivity facets and substance use involvement: insights from genomic structural equation modeling

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 16:49
  • Read more about Impulsivity facets and substance use involvement: insights from genomic structural equation modeling

Mendelian randomisation with proxy exposures: challenges and opportunities

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 16:46
  • Read more about Mendelian randomisation with proxy exposures: challenges and opportunities

Genetic architecture of lumbar spinal stenosis

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 16:25
  • Read more about Genetic architecture of lumbar spinal stenosis

GLP-1 Receptor Agonists and Risk of Paralytic Ileus: A drug-target Mendelian Randomization Study

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 16:20
  • Read more about GLP-1 Receptor Agonists and Risk of Paralytic Ileus: A drug-target Mendelian Randomization Study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 287
  • Page 288
  • Page 289
  • Page 290
  • Current page 291
  • Page 292
  • Page 293
  • Page 294
  • Page 295
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement